Literature DB >> 20027203

Synthetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of Opioid Receptor affinity.

Gianfranco Fontana1, Giuseppe Savona, Benjamín Rodríguez, Christina M Dersch, Richard B Rothman, Thomas E Prisinzano.   

Abstract

Salvinorin A (1), a neoclerodane diterpene from the hallucinogenic mint Salvia divinorum, is the only known non-nitrogenous and specific kappa-opioid agonist. Several structural congeners of 1 isolated from Salvia splendens (2 - 8) together with a series of semisynthetic derivatives (9 - 24), some of which possess a pyrazoline structural moiety (9, 19 - 22), have been tested for affinity at human mu, delta, and kappa opioid receptors. None of these compounds showed high affinity binding to these receptors. However, 10 showed modest affinity for kappa receptors suggesting other naturally neoclerodanes from different Salvia species may possess opioid affinity.

Entities:  

Year:  2008        PMID: 20027203      PMCID: PMC2766265          DOI: 10.1016/j.tet.2008.08.043

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  16 in total

1.  Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.

Authors:  Wayne W Harding; Matthew Schmidt; Kevin Tidgewell; Pavitra Kannan; Kenneth G Holden; Christina M Dersch; Richard B Rothman; Thomas E Prisinzano
Journal:  Bioorg Med Chem Lett       Date:  2006-04-18       Impact factor: 2.823

2.  Asymmetric synthesis of salvinorin A, a potent kappa opioid receptor agonist.

Authors:  Jonathan R Scheerer; Jonathan F Lawrence; Grace C Wang; David A Evans
Journal:  J Am Chem Soc       Date:  2007-06-30       Impact factor: 15.419

3.  Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide and related compounds at the cloned human delta-opioid receptor.

Authors:  H Xu; Y F Lu; J B Thomas; F I Carroll; K C Rice; R B Rothman
Journal:  Synapse       Date:  2001-06-15       Impact factor: 2.562

4.  Salvinorin A: allosteric interactions at the mu-opioid receptor.

Authors:  Richard B Rothman; Daniel L Murphy; Heng Xu; Jonathan A Godin; Christina M Dersch; John S Partilla; Kevin Tidgewell; Matthew Schmidt; Thomas E Prisinzano
Journal:  J Pharmacol Exp Ther       Date:  2006-10-23       Impact factor: 4.030

5.  Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.

Authors:  Thomas A Munro; Mark A Rizzacasa; Bryan L Roth; Beth A Toth; Feng Yan
Journal:  J Med Chem       Date:  2005-01-27       Impact factor: 7.446

6.  Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.

Authors:  David Y W Lee; Minsheng He; Leelakrishna Kondaveti; Lee-Yuan Liu-Chen; Zhongze Ma; Yulin Wang; Yong Chen; Jian-Guo Li; Cecile Beguin; William A Carlezon; Bruce Cohen
Journal:  Bioorg Med Chem Lett       Date:  2005-10-01       Impact factor: 2.823

7.  A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.

Authors:  Heng Xu; John S Partilla; Xiaoying Wang; John M Rutherford; Kevin Tidgewell; Thomas E Prisinzano; Laura M Bohn; Richard B Rothman
Journal:  Synapse       Date:  2007-03       Impact factor: 2.562

8.  Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.

Authors:  Wayne W Harding; Kevin Tidgewell; Nathan Byrd; Howard Cobb; Christina M Dersch; Eduardo R Butelman; Richard B Rothman; Thomas E Prisinzano
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

9.  Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway.

Authors:  Lukasz Kutrzeba; Franck E Dayan; J'Lynn Howell; Ju Feng; José-Luis Giner; Jordan K Zjawiony
Journal:  Phytochemistry       Date:  2007-06-14       Impact factor: 4.072

10.  Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa-opioid receptor.

Authors:  Yiqiang Li; Stephen M Husbands; Mary F Mahon; John R Traynor; Michael G Rowan
Journal:  Chem Biodivers       Date:  2007-07       Impact factor: 2.408

View more
  19 in total

1.  Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A.

Authors:  Katherine M Prevatt-Smith; Kimberly M Lovell; Denise S Simpson; Victor W Day; Justin T Douglas; Peter Bosch; Christina M Dersch; Richard B Rothman; Bronwyn Kivell; Thomas E Prisinzano
Journal:  Medchemcomm       Date:  2011-12       Impact factor: 3.597

2.  Probes for narcotic receptor mediated phenomena. Part 42: synthesis and in vitro pharmacological characterization of the N-methyl and N-phenethyl analogues of the racemic ortho-c and para-c oxide-bridged phenylmorphans.

Authors:  Jin-Hee Kim; Jeffrey R Deschamps; Richard B Rothman; Christina M Dersch; John E Folk; Kejun Cheng; Arthur E Jacobson; Kenner C Rice
Journal:  Bioorg Med Chem       Date:  2011-04-22       Impact factor: 3.641

Review 3.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

4.  Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity.

Authors:  Malliga R Iyer; Yong Sok Lee; Jeffrey R Deschamps; Christina M Dersch; Richard B Rothman; Arthur E Jacobson; Kenner C Rice
Journal:  Eur J Med Chem       Date:  2012-01-20       Impact factor: 6.514

5.  Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphans.

Authors:  Fuying Li; Jason A Deck; Christina M Dersch; Richard B Rothman; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice
Journal:  Eur J Med Chem       Date:  2012-10-30       Impact factor: 6.514

6.  Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylation.

Authors:  Hwan Jung Lim; Christina M Dersch; Richard B Rothman; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice
Journal:  Eur J Med Chem       Date:  2013-06-25       Impact factor: 6.514

7.  Probes for narcotic receptor mediated phenomena. 47. Novel C4a- and N-substituted-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-ols.

Authors:  Malliga R Iyer; Richard B Rothman; Christina M Dersch; Arthur E Jacobson; Kenner C Rice
Journal:  Bioorg Med Chem       Date:  2013-04-03       Impact factor: 3.641

8.  Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphans.

Authors:  Yi Zhang; Yong Sok Lee; Richard B Rothman; Christina M Dersch; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

9.  Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors.

Authors:  Denise S Simpson; Kimberly M Lovell; Anthony Lozama; Nina Han; Victor W Day; Christina M Dersch; Richard B Rothman; Thomas E Prisinzano
Journal:  Org Biomol Chem       Date:  2009-07-14       Impact factor: 3.876

Review 10.  Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse.

Authors:  Thomas E Prisinzano
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.